Cargando…

The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State

BACKGROUND: Opioid use disorder (OUD) is a serious health condition that is effectively treated with buprenorphine. However, only a minority of people with OUD are able to access buprenorphine. Many access points for buprenorphine have high barriers for initiation and retention. Health care and drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banta-Green, Caleb J., Owens, Mandy D., Williams, Jason R., Sears, Jeanne M., Floyd, Anthony S., Williams-Gilbert, Wendy, Kingston, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261214/ https://www.ncbi.nlm.nih.gov/pubmed/35799210 http://dx.doi.org/10.1186/s13722-022-00315-4

Ejemplares similares

Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program
por: Rowe, Christopher L., et al.
Publicado: (2022)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021)

Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program
por: Peavy, K. Michelle, et al.
Publicado: (2020)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington
por: Fockele, Callan Elswick, et al.
Publicado: (2021)

Changes in early high‐risk opioid prescribing practices after policy interventions in Washington State
por: Sears, Jeanne M., et al.
Publicado: (2020)

Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
por: Lambdin, Barrot H., et al.
Publicado: (2022)

A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers
por: Stoller, Kenneth B
Publicado: (2015)

Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone
por: Kline, Anna, et al.
Publicado: (2023)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Early High-Risk Opioid Prescribing Practices and Long-Term Disability Among Injured Workers in Washington State, 2002 to 2013
por: Haight, John R., et al.
Publicado: (2020)

Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study
por: Banta-Green, Caleb J, et al.
Publicado: (2019)

Community Treatment Programs Take Up Buprenorphine
por: Casadonte, Paul P., et al.
Publicado: (2004)

Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys
por: Salow, Katheryn, et al.
Publicado: (2023)

Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data
por: Alexandridis, Apostolos A., et al.
Publicado: (2020)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Routes of non-traditional entry into buprenorphine treatment programs
por: Champagne-Langabeer, Tiffany, et al.
Publicado: (2020)

A content review of buprenorphine training programs for pharmacists
por: Davis, Scott A., et al.
Publicado: (2022)

Systematic Review of the Safety and Tolerability of Injectable Prolonged-Release Buprenorphine (Buvidal) in Adults With Opioid Dependence
por: Williams, Laura, et al.
Publicado: (2023)

Use of the Washington Group Questions in Non-Government Programming
por: Robinson, Alex, et al.
Publicado: (2021)

Treatment of opioid dependence with buprenorphine: current update
por: Soyka, Michael
Publicado: (2017)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)
por: D’Onofrio, Gail, et al.
Publicado: (2019)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
por: Jakubowski, Andrea, et al.
Publicado: (2022)

Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder
por: Berry, Amanda R. W., et al.
Publicado: (2021)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department–Initiated Buprenorphine Programs
por: Sue, Kimberly L., et al.
Publicado: (2023)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Federally Qualified Health Centers Can Expand Rural Access to Buprenorphine for Opioid Use Disorder in Arizona
por: Brady, Benjamin R, et al.
Publicado: (2021)

Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
por: Ling, Walter, et al.
Publicado: (2019)

Pattern of buprenorphine abuse among opioid abusers in Nepal
por: Aich, Tapas Kumar, et al.
Publicado: (2010)

Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Opioid-Dependents
por: Ziaaddini, Hassan, et al.
Publicado: (2012)

Sleep problems in opioid dependent patients maintained on buprenorphine
por: Tripathi, R., et al.
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ebdlm4fntk0gsr81meovmtuqdf